EUVIMEDEUVIMED entdecken
Crossref

Combining Pr 3+ -Doped Nanoradiosensitizers and Endogenous Protoporphyrin IX for X-ray-Mediated Photodynamic Therapy of Glioblastoma Cells

Gabrielle A Mandl iD, Freesia Vettier, Gabriella Tessitore iD, Steven L Maurizio iD, Kais Bietar iD, Ursula Stochaj iD, John A Capobianco iD

ACS Applied Bio Materials · 2023

DOI: 10.1021/acsabm.3c00201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2023. Verfasst von Gabrielle A Mandl und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry & Centre for Nanoscience Research, Concordia University, 7141 Sherbrooke St. W., Montreal, Quebec H4B 1R6, C…. Hauptthemen laut MEDLINE: Glioblastoma, Photochemotherapy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: McGill University, Concordia University, Government of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaPhotochemotherapyHumansX-RaysCell Line, TumorAminolevulinic AcidProtoporphyrins

Stichwörter der Autor:innen

X-raysglioblastomalanthanidesphotodynamic therapyprotoporphyrin IXradioluminescenceradiosensitizerradiotherapy

Substanzen

Aminolevulinic Acidprotoporphyrin IXProtoporphyrins

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry & Centre for Nanoscience Research, Concordia University, 7141 Sherbrooke St. W., Montreal, Quebec H4B 1R6, Canada.
  • Department of Physiology, McGill University, Montreal, Quebec H3G 1Y6, Canada.

ORCID-Profile: Gabrielle A Mandl, Gabriella Tessitore, Steven L Maurizio, Kais Bietar, Ursula Stochaj, John A Capobianco

Förderung

  • McGill University
  • Concordia University
  • Government of Canada
  • Fonds de recherche du Qu??bec - Nature et technologies

Zitieren

APA

Mandl, G. A., Vettier, F., Tessitore, G., Maurizio, S. L., Bietar, K., Stochaj, U., & Capobianco, J. A. (2023). Combining Pr 3+ -Doped Nanoradiosensitizers and Endogenous Protoporphyrin IX for X-ray-Mediated Photodynamic Therapy of Glioblastoma Cells. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.3c00201

Vancouver

Mandl GA, Vettier F, Tessitore G, Maurizio SL, Bietar K, Stochaj U, et al. Combining Pr 3+ -Doped Nanoradiosensitizers and Endogenous Protoporphyrin IX for X-ray-Mediated Photodynamic Therapy of Glioblastoma Cells. ACS Applied Bio Materials. 2023. doi:10.1021/acsabm.3c00201

BibTeX
@article{Mandl2023,
  author = {Mandl, Gabrielle A and Vettier, Freesia and Tessitore, Gabriella and Maurizio, Steven L and Bietar, Kais and Stochaj, Ursula and Capobianco, John A},
  title = {Combining Pr 3+ -Doped Nanoradiosensitizers and Endogenous Protoporphyrin IX for X-ray-Mediated Photodynamic Therapy of Glioblastoma Cells},
  journal = {ACS Applied Bio Materials},
  year = {2023},
  doi = {10.1021/acsabm.3c00201}
}
Kostenlos starten →